Principal Financial Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $374K | Buy |
|
|||||
|
2025
Q2 | $276K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $381K | Sell |
|
|||||
|
2024
Q1 | $2.76M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $592K | Buy |
|
|||||
|
2022
Q2 | $534K | Sell |
|
|||||
|
2022
Q1 | $553K | Sell |
|
|||||
|
2021
Q4 | $694K | Sell |
|
|||||
|
2021
Q3 | $1.7M | Sell |
|
|||||
|
2021
Q2 | $2.85M | Buy |
|
|||||
|
2021
Q1 | $1.92M | Buy |
|